Youpei Lin

1.3k total citations
15 papers, 173 citations indexed

About

Youpei Lin is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Youpei Lin has authored 15 papers receiving a total of 173 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in Youpei Lin's work include Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), RNA modifications and cancer (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Youpei Lin is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), RNA modifications and cancer (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Youpei Lin collaborates with scholars based in China, Ethiopia and Bulgaria. Youpei Lin's co-authors include Qiang Gao, Tiancheng Zhang, Jia Fan, Liangqing Dong, Xiaoying Wang, Daming Gao, Jiaomeng Pan, Shu Zhang, Shuang–Jian Qiu and Jian Zhou and has published in prestigious journals such as Cancer Research, Carcinogenesis and eLife.

In The Last Decade

Youpei Lin

12 papers receiving 172 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youpei Lin China 7 74 62 41 29 29 15 173
Marie Mack United States 5 54 0.7× 83 1.3× 36 0.9× 39 1.3× 41 1.4× 7 193
Lu Pei China 10 124 1.7× 73 1.2× 36 0.9× 50 1.7× 42 1.4× 20 227
Jiangzheng Zeng China 9 98 1.3× 47 0.8× 71 1.7× 35 1.2× 30 1.0× 20 194
Ian Y. Luk Australia 9 134 1.8× 61 1.0× 48 1.2× 29 1.0× 33 1.1× 11 214
Sarah Cappuyns Belgium 6 75 1.0× 78 1.3× 53 1.3× 40 1.4× 35 1.2× 12 205
Soren Charmsaz United States 8 73 1.0× 103 1.7× 40 1.0× 24 0.8× 61 2.1× 15 184
María José Paúles Spain 6 53 0.7× 134 2.2× 39 1.0× 34 1.2× 29 1.0× 14 198
María Ochoa-de-Olza Spain 5 117 1.6× 116 1.9× 73 1.8× 50 1.7× 62 2.1× 7 243
Fumiaki Shiratori Japan 10 79 1.1× 98 1.6× 47 1.1× 56 1.9× 56 1.9× 35 223
Anke Van Lierop Germany 7 89 1.2× 146 2.4× 35 0.9× 43 1.5× 36 1.2× 9 236

Countries citing papers authored by Youpei Lin

Since Specialization
Citations

This map shows the geographic impact of Youpei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youpei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youpei Lin more than expected).

Fields of papers citing papers by Youpei Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youpei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youpei Lin. The network helps show where Youpei Lin may publish in the future.

Co-authorship network of co-authors of Youpei Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Youpei Lin. A scholar is included among the top collaborators of Youpei Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youpei Lin. Youpei Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Zhao, Haoliang, Yifei Cheng, Qianxi Wang, et al.. (2025). Harnessing alternative splicing for off-the-shelf mRNA neoantigen vaccines in hepatocellular carcinoma. Cell Research. 35(12). 970–986.
2.
Zhang, Juan, Xiaojian Ni, Youpei Lin, et al.. (2025). AGEs-RAGE manipulates tumor intrinsic pERK/Sp1/IL6 pathway and reprograms macrophage to promote intrahepatic cholangiocarcinoma progression. Translational Oncology. 60. 102446–102446.
3.
Sang, Chen, Yan Li, Jian Lin, et al.. (2024). Identification and validation of a lactate metabolism-related six-gene prognostic signature in intrahepatic cholangiocarcinoma. Journal of Cancer Research and Clinical Oncology. 150(4). 199–199. 6 indexed citations
4.
Ding, Guangyu, Weimin Tan, Youpei Lin, et al.. (2024). Mining the interpretable prognostic features from pathological image of intrahepatic cholangiocarcinoma using multi-modal deep learning. BMC Medicine. 22(1). 282–282. 9 indexed citations
5.
Liao, Haotian, Haichuan Wang, Youpei Lin, et al.. (2024). Whole-Genome DNA Methylation Profiling of Intrahepatic Cholangiocarcinoma Reveals Prognostic Subtypes with Distinct Biological Drivers. Cancer Research. 84(11). 1747–1763. 7 indexed citations
6.
Liu, Yuming, et al.. (2023). SSH1 promotes progression of intrahepatic cholangiocarcinoma via p38 MAPK-CXCL8 axis. Carcinogenesis. 44(3). 232–241. 4 indexed citations
7.
Zhu, Hongwen, Youpei Lin, Dayun Lu, et al.. (2023). Proteomics of adjacent-to-tumor samples uncovers clinically relevant biological events in hepatocellular carcinoma. National Science Review. 10(8). nwad167–nwad167. 21 indexed citations
8.
Zhang, Tiancheng, Youpei Lin, & Qiang Gao. (2023). Bispecific antibodies targeting immunomodulatory checkpoints for cancer therapy. Cancer Biology and Medicine. 20(3). 181–195. 42 indexed citations
9.
Xu, Xin, Xiaojian Ni, Jiaomeng Pan, et al.. (2023). Gene-based cancer-testis antigens as prognostic indicators in hepatocellular carcinoma. Heliyon. 9(3). e13269–e13269. 3 indexed citations
10.
Liu, Yuming, Zhuo Wang, Jiaqiang Ma, et al.. (2022). Multi-omics characterization reveals the pathogenesis of liver focal nodular hyperplasia. iScience. 25(9). 104921–104921. 2 indexed citations
11.
Pan, Jiaomeng, Mao Zhang, Liangqing Dong, et al.. (2022). Genome-Scale CRISPR screen identifies LAPTM5 driving lenvatinib resistance in hepatocellular carcinoma. Autophagy. 19(4). 1184–1198. 60 indexed citations
12.
Lin, Youpei, Huanhuan Chong, Guohe Song, et al.. (2021). The influence of 18F-fluorodeoxyglucose positron emission tomography/computed tomography on the N- and M-staging and subsequent clinical management of intrahepatic cholangiocarcinoma. HepatoBiliary Surgery and Nutrition. 11(5). 684–695. 7 indexed citations
13.
Lin, Youpei, Wenrui Ma, Jiannan Liu, et al.. (2021). A pre-screening strategy to assess resected tumor margins by imaging cytoplasmic viscosity and hypoxia. eLife. 10. 2 indexed citations
14.
Zhang, Chenhao, Ming Li, Youpei Lin, & Qiang Gao. (2020). Systemic Therapy for Hepatocellular Carcinoma: Advances and Hopes. Current Gene Therapy. 20(2). 84–99. 10 indexed citations
15.
Song, Guohe, Yang Shi, Youpei Lin, et al.. (2020). Abstract PO-055: Global immune characterization of hepatocellular carcinoma identifies macrophage and T cell subsets related to disease progression. Cancer Research. 80(21_Supplement). PO–55.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026